{
  "title": "The Outlook for COVID-19 Antibody Treatments",
  "itunes:title": "The Outlook for COVID-19 Antibody Treatments",
  "description": "<p>Bloomberg Businessweek Editor Joel Weber and Bloomberg News Health Care Reporter Robert Langreth talk about the potential for antibody treatments to be the best hope against the coronavirus until a vaccine is found. Dr. Ellen Wald, President of Transversal Consulting, discusses oil plunging to its lowest since 1986. Bloomberg New Economy Editorial Director Andy Browne shares his insight on how the pandemic may speed Asia’s rise. And we Drive to the Close with Jeff Krumpelman, Chief Investment Strategist at Mariner Wealth Advisors.</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.</p><p><br></p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Bloomberg Businessweek Editor Joel Weber and Bloomberg News Health Care Reporter Robert Langreth talk about the potential for antibody treatments to be the best hope against the coronavirus until a vaccine is found. Dr. Ellen Wald, President of Transversal Consulting, discusses oil plunging to its lowest since 1986. Bloomberg New Economy Editorial Director Andy Browne shares his insight on how the pandemic may speed Asia’s rise. And we Drive to the Close with Jeff Krumpelman, Chief Investment Strategist at Mariner Wealth Advisors.</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.</p><p><br></p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "4e435190-8368-11ea-affc-4fd30f08f86e",
  "omny:clipId": "ecb1393f-3560-41f6-897d-ae2b0079e332",
  "pubDate": "Tue, 21 Apr 2020 00:40:34 +0000",
  "itunes:duration": 1722,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-businessweek/the-outlook-for-covid-19-antibody-treatments"
}